Neurocrine Biosciences | 販売および管理費





販売および管理費 変化する 日付
AbbVie USD 3.25B 40M 2025-06
Acadia Pharmaceuticals USD 124.9M 1.24M 2025-09
Agios Pharmaceuticals USD 41.27M 4.6M 2025-09
ALKERMES USD 171.77M 17.9M 2025-09
Alnylam Pharmaceuticals USD 262.59M 60.72M 2025-09
Amgen USD 1.7B 9M 2025-09
Biogen USD 545.2M 38.6M 2025-09
BioMarin Pharmaceutical USD 223.42M 8.86M 2025-09
Cytokinetics USD 158.75M 93.03M 2025-09
Dynavax Technologies USD 40.09M 1.45M 2025-09
Exelixis USD 103.13M 9.8M 2025-09
Gilead Sciences USD 1.35B 6M 2025-09
Halozyme Therapeutics USD 37.53M 4.53M 2025-09
Incyte USD 329.08M 1.94M 2025-09
Ionis Pharmaceuticals USD 86.56M 4.04M 2025-09
Neurocrine Biosciences USD 291.6M 5.3M 2025-09
Pfizer USD 3.19B 209M 2025-09
Prothena USD 13.24M 2.67M 2025-09
Regeneron Pharmaceuticals USD 775M 117.2M 2025-12
Repligen USD 73.66M 2.43M 2025-09
Sarepta Therapeutics USD 77.11M 7.22M 2025-09
Teva Pharmaceutical Industries USD 1.12B 147M 2025-12
Ultragenyx Pharmaceutical USD 86.62M 26K 2025-09
Vertex Pharmaceuticals USD 445.1M 20.5M 2025-09


Neurocrine Biosciences 販売および管理費 - 現在の値は、過去のデータ、予測、統計、チャートや経済カレンダー - Feb 2026.